Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

M.D. Anderson Cancer Center to guide arglabin preclinical studies

Jan. 18, 2000

Matrix completes patient enrollment in pivotal head and neck cancer trials

Jan. 17, 2000

Nippon Kayaku devotes significant resources to the fight against cancer

Jan. 17, 2000

Porphyrin-based agents for PDT and MRI designed at Schering AG

Jan. 17, 2000

Kinase-inhibitory antiproliferative indolones in development at Boehringer Ingelheim

Jan. 17, 2000

Mechanism of MDR reversal by TER-199 under investigation

Jan. 14, 2000

Access files IND for amlexanox oral rinse

Jan. 14, 2000

ImClone Systems achieves milestone in IMC-C225 collaboration with Merck KGaA

Jan. 13, 2000

Cephalon's CEP-701 enters phase II trials in prostate cancer

Jan. 13, 2000

FDA to review Aptosyn NDA without ODAC input

Jan. 13, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...